The global Vitamin B6 market exhibited a weakening trend during Q2’25, driven primarily by persistent oversupply conditions and subdued downstream demand across major regions. In the Asia-Pacific, particularly China, continuous production at high operating rates led to significant inventory accumulation, prompting aggressive price reductions to stimulate buying interest. Despite stable logistics and smooth export operations, weak procurement from international buyers limited market recovery. In Europe, similar bearish sentiment prevailed as high inventory levels and consistent inflows from Asian exporters created a buyer-dominated market. Demand from the pharmaceutical and nutraceutical sectors remained lackluster, with minimal restocking activity and cautious purchasing behavior. North America mirrored this trend, where reliance on imports amplified the impact of global oversupply. Elevated domestic inventories and deferred buying patterns from end-use industries further pressured the market. Although the quarter began with slight stability supported by balanced supply-demand conditions, the absence of strong consumption triggers led to a sharp correction by June, establishing an overall soft global outlook.